Author:
Griffith David E.,Aksamit Timothy R.
Subject
Cardiology and Cardiovascular Medicine,Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine
Reference53 articles.
1. Diagnosis and treatment of disease caused by nontuberculous mycobacteria;Wallace;Am J Respir Crit Care Med,1997
2. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007;175(4):367-416];Griffith;Am J Respir Crit Care Med,2007
3. Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/ /IDSA Clinical Practice Guideline;Daley;Clin Infect Dis,2020
4. Randomized trial of liposomal amikacin for inhalation in nontuberculous mycobacterial lung disease;Olivier;Am J Respir Crit Care Med,2017
5. Amikacin liposome inhalation suspension for treatment-refractory lung disease caused by Mycobacterium avium complex (CONVERT): a prospective, open-label, randomized study;Griffith;Am J Respir Crit Care Med,2018
Cited by
27 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献